Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ: BVS )

9.580 +0.030 (+0.31%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
Bioventus's Return on Invested Capital Overview
Via Benzinga
What 4 Analyst Ratings Have To Say About Bioventus
Via Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Bioventus Inc. (BVS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
NASDAQ:BVS Investor Alert: Investigation over Possible Securities Laws Violations by Bioventus Inc.
San Diego, CA -- (SBWIRE) -- 11/29/2022 -- An investigation was announced for investors of Bioventus Inc. (NASDAQ:BVS) shares over potential securities laws violations by Bioventus Inc. 
Via SBWire
3 Analysts Have This to Say About Bioventus
Analysts have provided the following ratings for Bioventus (NASDAQ:BVS) within the last quarter: 
Via Benzinga
Why Shares of Bioventus Fell 14% on Wednesday
The company's reduced guidance concerned investors. 
Via The Motley Fool
What Does Bioventus's Debt Look Like?
Over the past three months, shares of Bioventus Inc. (NASDAQ:BVS) moved lower by 57.38%. Before we understand the importance of debt, let's look at how much debt Bioventus has. 
Via Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Bioventus Inc. (BVS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Bioventus Inc. (BVS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Bioventus Inc. Investors to Inquire About Securities Class Action Investigation – BVS
From The Rosen Law Firm, P.A.
Via Business Wire
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo. 
Via Benzinga
US Stocks Start Week On Lower Note, Dow Drops Over 100 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Monday. 
Via Benzinga
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
From Bioventus, Inc.
Via GlobeNewswire
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share. 
Via Benzinga
Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022
From Bioventus, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  On Friday, 64 companies achieved new lows for the year. 
Via Benzinga
Where Bioventus Stands With Analysts
Over the past 3 months, 3 analysts have published their opinion on Bioventus (NASDAQ:BVS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Bioventus Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday. 
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Bioventus Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022
Upgrades 
Via Benzinga
Nasdaq Turns Lower; Expeditors International Posts Upbeat Q3 Results
U.S. stocks pared gains toward the end of trading, with the S&P and the Nasdaq Composite turning lower on Tuesday. 
Via Benzinga
Nasdaq Jumps 150 Points; Gold Rises Over 2%
U.S. stocks traded extended gains midway through trading, with the Nasdaq Composite gaining around 150 points on Tuesday. 
Via Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. 
Via Benzinga
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast... 
Via Benzinga
Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
Full Launch of BoneScalpel® Access™ at NASS 
From Bioventus, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.